Abstract CD11/CD18 leucocyte glycoprotein deficiency is a rare, congenital adhesion molecule disorder which, in its severe form, is usually fatal. Leucocytes in affected subjects have abnormal migration and adherence, rendering patients susceptible to life threatening infections. The CD11/ CD18 integrins, and other adehsion molecules, are considered essential to the normal inflammatory response. It has been postulated that adhesion molecules may be responsible for mediating in part, the inflammatory changes observed in inflammatory bowel diseases and related disorders. This report describes the first case of CD11/CD18 deficiency characterised by a chronic ileocolitis. Bone marrow transplantation completely resolved the gastrointestinal symptoms, supporting a role for neutrophil dysfunction in the pathogenesis of the gut lesions. This case suggests that specific blockade of CD11/ CD18 integrins alone may not halt the chronic inflammatory response observed in immune mediated bowel disorders, and that abnormalities of leucocyte function must be included in the differential diagnosis of paediatric Crohn's disease.
Considerable interest has recently been focused on adhesion molecules and their involvement in phagocyte-endothelial interactions and lymphocyte homing.' 2 Ligands for CD11/CD18 expressed on endothelial cells help mediate their interaction with polymorphonuclear cells (PMN) and monocytes.3 Expression of a number of leucocyte adhesion molecules such as LFA-1, Mac-i, (CD54) are upregulated by pro-inflammatory cytokines and other mediators in inflammatory states. Quantitative abnormalities in adhesion molecules and the cytokines that induce their expression have been reported in patients with inflammatory bowel disease.f7 Consequently, it has been postulated that specific blockade of adhesion molecules by monoclonal antibodies may attenuate the damage resulting from leucocyte activity at inflammatory sites, and thus be of therapeutic benefit to patients with inflammatory bowel disease.2 4 CD1 1/CD18 leucocyte glycoprotein deficiency is a rare, inherited disorder that presents in infancy under the guise of recurrent and often fatal bacterial infections. 8 9 The leucocytes of affected patients are characterised by an absent or deficient expression of plasmalemma glcoproteins LFA-1 (CD1 la/CD 18), Mac-i (CD1 lb/CD18), and p160,95 (CD1 lc/CD18), members of the leucocyte integrin family. These molecules are essential for many leucocyte adhesion related functions, including chemotaxis, aggregation, phagocytosis, and antibody directed cellular cytotoxicity. In the approximately 60 cases reported to date, the typical presentation was delayed separation of the umbilical cord, recurrent episodes of septicaemia, skin and wound infections, as well as severe gingival and periodontal disease. Gastrointestinal tract involvement has been reported in only a few cases, including appendicitis, peritonitis, ischaemic ileitis, and necrotising enterocolitis.' 0 l Inflammatory bowel diseaselike signs and symptoms have been described in several other congenital disorders of leucocyte function,'2 such as chronic granulomatous disease. In this report, we provide the first description of a chronic ileocolitis in a patient with congenital CD1 1/CD18 deficiency that resolved after successful bone marrow transplantation.
Case report A male born to non-consanguineous FrenchCanadian parents presented at three months of age with high fever, gastroenteritis, and a slowly healing lesion at the site of his first immunisation. Six admissions ensued over the following 15 months for episodes of fever of unknown origin, pustular and ulcerated lesions of the skin and lip, pneumonia, a perianal abscess requiring drainage, and balanopostitis resulting in phimosis. Each admission was characterised by high fevers (to 40°C), leucocytosis (average of 28 000, up to 70 000 cells/ ml) with neutrophilia (70-90%), and a slow response to multiple antibiotics. The immunological examination of this patient has been reported in detail previously ( CD 1 1b or CD 1 1 c) , and a common 1 subunit (CD18). Each member of the CD11/CD18 family mediates specific, as well as overlapping leucocyte adhesion related functions. 1-3 Abnormal expression of the gene for the 1B subunit results in an inability of normal surface membrane expression of these three heterodimers. Two phenotypic variants of the disorder exist, based on the degree to which CD11/CD18 expression is impaired."
The case presented in this report may be regarded as an accident of nature that allows us to examine the consequences of human CD11/CD18 'gene knock-out' from the gastrointestinal point of view. Chronic diarrhoea, often accompanied by malabsorption and failure to thrive, is characteristic of several primary immunodeficiency syndromes. ' 29 However, other CD11/CD18 independent pathways of inflammation have been shown to exist.30 Furthermore, in another leucocyte disorder in which integrin expression is normal but the selectin system is crippled, gastrointestinal symptoms are not prominent.31 Obviously, anti-CD11/CD18 monoclonal antibodies in our patient would have been of no benefit whatsoever. This does not guarantee that anti-CD 11/CD18 monoclonal antibody therapy is devoid of benefit in Crohn's disease, as the pathological mechanisms involved in leucocyte adhesion deficiency associated ileocolitis may differ from those operating in Crohn's disease.
In this report, we have described the development of an inflammatory bowel diseaselike illness in a child with congenital CD I1/ CD 18 deficiency. This disorder thus represents yet another example of a primary immunodeficiency syndrome involving neutrophils, which may present with a non-specific enterocolitis. Disorders of neutrophil function should be included in the differential diagnosis of paediatric Crohn's disease,'2 16 particularly in the presence of severe stomatitis and periodontal disease. This case also suggests that, to control inflammation in inflammatory bowel disease, targeting one adhesion molecule, such as LFA-1 of the CD1 1/CD18 complex, is probably not sufficient. 
